Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:

Comment by mba123ccuon Jun 15, 2022 9:11am

RE:News again BVX-0918 Vaccine Process Development

This is a critical stage, if successful hope we can see rapid progress.

Discussion

Post by frankmanon Jun 15, 2022 8:43am

News again BVX-0918 Vaccine Process Development

Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development VANCOUVER, BC, June 15, 2022 /PRNewswire ...more

117

Discussion

QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp

posted Nov 25, 2024 9:00am by Q Precious & Battery Metals Corp.

The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more

(0)
•••

Post by PressReleaseon Jun 15, 2022 8:00am

New Press Release - Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

VANCOUVER, BC, June 15, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator Hospices Civils de Lyon in France ("HCL") has surgically excised the first ovarian cancer tumors from cancer...read article.

Post by Rossaporinoon Jun 11, 2022 8:40pm

Covid testing

https://www.swansonreed.com/inotiv-inc-to-evaluate-biovaxys-covidth/

187

Post by Rossaporinoon Jun 10, 2022 12:45pm

Eguity guru

https://equity.guru/2022/06/10/the-millennial-sweet-tooth-sector-roundup-week-10/

136

Post by 1DoxieDollaron Jun 10, 2022 11:34am

Article in France this morning-BIOV

https://www.lequotidiendumedecin.fr/specialites/cancerologie/lyon-fait-le-choix-de-lhaptenisation-pour-un-candidat-developpe-avec-biovaxys

120

Post by Rossaporinoon Jun 09, 2022 7:16pm

Interview

https://m.youtube.com/watch?v=xoJk7UC6jns

187

Post by frankmanon Jun 08, 2022 2:35pm

.125 other market bid ask

14:09:51 O 0.125 0.015 5,000 1 Anonymous Ask 0.145 11,500 1 0.14 3,000 1 ...more

111

Post by frankmanon Jun 08, 2022 9:46am

Level 2 bid and ask

Ask 0.135 11,000 1 0.13 1,000 1 0.125 1,000 1 0.12 9,000 1 0.115 ...more

Comment by mba123ccuon Jun 08, 2022 8:47am

RE:News Bio-Manufacturing Partner BioElpida Completes Next Phas

"Completion of OVCAR-3 cell banks is another step towards our ability to produce GMP yields of BVX-0918, and brings us closer to our Phase I study in the EU planned for later this year." ...more

103

Discussion

Post by frankmanon Jun 08, 2022 8:35am

News Bio-Manufacturing Partner BioElpida Completes Next Phas

Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study VANCOUVER, BC, June 8, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) ...more

139

Discussion

(0)
•••

Post by PressReleaseon Jun 08, 2022 8:00am

New Press Release - Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

VANCOUVER, BC, June 8, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its Lyon, France-based bioproduction partner, BioElpida ("BioElpida"), has completed the creation of multiple OVCAR-3 cell banks as the next...read article.

Post by frankmanon Jun 06, 2022 12:26pm

Develpments of vaccines are picking up speed here

After the two year covid delay. Picked up two new de bulked tumour suppliers for the cancer vaccine research. Nudged CEO Passin to speed up product development. Should have lots of news going forward ...more

160

Comment by Humaniston Jun 03, 2022 1:38pm

RE:Note this part of the nr

excellent highlight frankman, the fact they invited tem again to get an update shows strong interest and faith in their reserach. and for us investors, means biovayxys has agreat potential of reaching ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

Bullboard (CSE:BIOV)

RE:News again BVX-0918 Vaccine Process Development

News again BVX-0918 Vaccine Process Development

QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp

New Press Release - Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

Covid testing

Eguity guru

Article in France this morning-BIOV

Interview

.125 other market bid ask

Level 2 bid and ask

RE:News Bio-Manufacturing Partner BioElpida Completes Next Phas

News Bio-Manufacturing Partner BioElpida Completes Next Phas

New Press Release - Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

Develpments of vaccines are picking up speed here

RE:Note this part of the nr

Featured News Links

One Property, One Focus on Advancing this Gold Project in Ontario

Options Trading for Retiring: Key Strategies in Balancing Retirement Income

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (CSE:BIOV)

Featured News Links